Intellia Therapeutics Return on Net Operating Assets Trends

Intellia Therapeutics, Inc. (NTLA)

9.30 -0.14 (-1.48%) USD | NASDAQ | Dec 09, 16:00

9.19 -0.11 (-1.18%) Pre-Market: 09:13

View Return on Net Operating Assets for NTLA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

ANI Pharmaceuticals, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Beam Therapeutics, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade
Pacific Biosciences of California, Inc.	Upgrade

Return on Equity	Upgrade
Return on Assets	Upgrade
Return on Invested Capital	Upgrade
Profit Margin (Quarterly)	Upgrade
Gross Profit Margin (Quarterly)	Upgrade
Operating Margin (Quarterly)	Upgrade